Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 662

1.

High seroprevalence of HBV and HCV infection in HIV-infected adults in Kigali, Rwanda.

Rusine J, Ondoa P, Asiimwe-Kateera B, Boer KR, Uwimana JM, Mukabayire O, Zaaijer H, Mugabekazi J, Reiss P, van de Wijgert JH.

PLoS One. 2013 May 22;8(5):e63303. doi: 10.1371/journal.pone.0063303.

2.

Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.

Rai RR, Mathur A, Mathur D, Udawat HP, Nepalia S, Nijhawan S, Mathur A.

Trop Gastroenterol. 2007 Jan-Mar;28(1):19-23.

PMID:
17896605
3.

Presence of occult HBV, but near absence of active HBV and HCV infections in people infected with HIV in rural South Africa.

Barth RE, Huijgen Q, Tempelman HA, Mudrikova T, Wensing AM, Hoepelman AI.

J Med Virol. 2011 Jun;83(6):929-34. doi: 10.1002/jmv.22026.

PMID:
21503902
4.

Seroprevalence of hepatitis B and C viruses among HIV-infected pregnant women in Uganda and Rwanda.

Pirillo MF, Bassani L, Germinario EA, Mancini MG, Vyankandondera J, Okong P, Vella S, Giuliano M.

J Med Virol. 2007 Dec;79(12):1797-801.

PMID:
17935164
5.

Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China.

Chen X, He JM, Ding LS, Zhang GQ, Zou XB, Zheng J.

Arch Virol. 2013 Sep;158(9):1889-94. doi: 10.1007/s00705-013-1681-z.

PMID:
23553454
6.

Occult hepatitis B virus infection in a cohort of HIV-positive patients: correlation with hepatitis C virus coinfection, virological and immunological features.

Morsica G, Ancarani F, Bagaglio S, Maracci M, Cicconi P, Cozzi Lepri A, Antonucci G, Bruno R, Santantonio T, Tacconi L, Baldelli F, Piscopo R, Santoro D, Lazzarin A, D'Arminio Monforte A; HepaICONA and the ICONA Study Groups..

Infection. 2009 Oct;37(5):445-9. doi: 10.1007/s15010-008-8194-9.

PMID:
19669092
7.

Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients.

Otegbayo JA, Taiwo BO, Akingbola TS, Odaibo GN, Adedapo KS, Penugonda S, Adewole IF, Olaleye DO, Murphy R, Kanki P.

Ann Hepatol. 2008 Apr-Jun;7(2):152-6.

PMID:
18626434
8.

High rates of active hepatitis B and C co-infections in HIV-1 infected Cameroonian adults initiating antiretroviral therapy.

Laurent C, Bourgeois A, Mpoudi-Ngolé E, Kouanfack C, Ciaffi L, Nkoué N, Mougnutou R, Calmy A, Koulla-Shiro S, Ducos J, Delaporte E.

HIV Med. 2010 Jan;11(1):85-9. doi: 10.1111/j.1468-1293.2009.00742.x.

9.

Hepatitis B virus and hepatitis C virus infection among HIV-1-infected injection drug users in Dali, China: prevalence and infection status in a cross-sectional study.

Dong Y, Qiu C, Xia X, Wang J, Zhang H, Zhang X, Xu J.

Arch Virol. 2015 Apr;160(4):929-36. doi: 10.1007/s00705-014-2311-0.

PMID:
25616842
10.

Prevalence and impact of hepatitis B and C virus co-infections in antiretroviral treatment naïve patients with HIV infection at a major treatment center in Ghana.

Sagoe KW, Agyei AA, Ziga F, Lartey M, Adiku TK, Seshi M, Arens MQ, Mingle JA.

J Med Virol. 2012 Jan;84(1):6-10. doi: 10.1002/jmv.22262.

PMID:
22095533
11.

Overt and occult hepatitis B virus infection in adult Sudanese HIV patients.

Mudawi H, Hussein W, Mukhtar M, Yousif M, Nemeri O, Glebe D, Kramvis A.

Int J Infect Dis. 2014 Dec;29:65-70. doi: 10.1016/j.ijid.2014.07.004.

12.

Seroprevalence of hepatitis B and C viruses and risk factors in HIV infected children at the Felgehiwot referral hospital, Ethiopia.

Abera B, Zenebe Y, Mulu W, Kibret M, Kahsu G.

BMC Res Notes. 2014 Nov 25;7:838. doi: 10.1186/1756-0500-7-838.

13.

Hepatitis B, C seroprevalence and delta viruses in HIV-1 Senegalese patients at HAART initiation (retrospective study).

Diop-Ndiaye H, Touré-Kane C, Etard JF, Lô G, Diaw P, Ngom-Gueye NF, Gueye PM, Ba-Fall K, Ndiaye I, Sow PS, Delaporte E, Mboup S.

J Med Virol. 2008 Aug;80(8):1332-6. doi: 10.1002/jmv.21236.

PMID:
18551596
14.

Hepatitis B virus prevalence and vaccine response in HIV-infected children and adolescents on combination antiretroviral therapy in Kigali, Rwanda.

Mutwa PR, Boer KR, Rusine JB, Muganga N, Tuyishimire D, Reiss P, Lange JM, Geelen SP.

Pediatr Infect Dis J. 2013 Mar;32(3):246-51. doi: 10.1097/INF.0b013e318271b93d.

PMID:
22976050
15.

Prevalence of human immunodeficiency virus, hepatitis C virus, hepatitis B virus and syphilis among individuals attending anonymous testing for HIV in Luanda, Angola.

Guimarães Nebenzahl H, Lopes A, Castro R, Pereira F.

S Afr Med J. 2013 Jan 24;103(3):186-8. doi: 10.7196/samj.6097.

PMID:
23472697
16.

Triple positivity of HBsAg, anti-HCV antibody, and HIV and their influence on CD4+ lymphocyte levels in the highly HIV infected population of Abeokuta, Nigeria.

Ogwu-Richard SO, Ojo DA, Akingbade OA, Okonko IO.

Afr Health Sci. 2015 Sep;15(3):719-27. doi: 10.4314/ahs.v15i3.4.

17.

Hepatitis B and/or C co-infection in HIV infected patients: a study in a tertiary care centre from South India.

Chandra N, Joshi N, Raju YS, Kumar A, Teja VD.

Indian J Med Res. 2013 Dec;138(6):950-4.

19.

Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy.

Cohen Stuart JW, Velema M, Schuurman R, Boucher CA, Hoepelman AI.

J Med Virol. 2009 Mar;81(3):441-5. doi: 10.1002/jmv.21422.

PMID:
19152397
20.

Interference of replication between hepatitis B and C viruses in patients infected with HIV.

Yang RR, Gui X, Chen XY, Zhu Y.

J Med Virol. 2011 Jul;83(7):1159-64. doi: 10.1002/jmv.22102.

PMID:
21567419
Items per page

Supplemental Content

Support Center